IMMH-010 (maleate)
IMMH-010 maleate is a prodrug that serves as a novel PD-L1 inhibitor, exhibiting potential antitumor activity for the treatment of neurological disorders and advanced malignant solid tumors. IMMH-010 maleate is rapidly converted to its active form, YPD-29B, following oral administration. IMMH-010 maleate is poised for advancing research in the field of PD-L1 inhibitors and related therapeutic applications.
Product Specifications
CAS Number
2541982-47-0
UNSPSC
12352101
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/immh-010-maleate.html
Purity
99.80
Smiles
OC(/C=C\C(O)=O)=O.CC(C)OC([C@H](CO)NCC(C=C(C(OCC1=C(C(C2=CC=CC=C2)=CC=C1)Br)=C3)Cl)=C3OCC4=CN=CC=C4)=O
Molecular Formula
C36H36BrClN2O9
Molecular Weight
756.04
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mucin 5AC (MUC5AC) (45M1), CF740 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
Eosinophil Peroxidase (AHE-1), CF640R conjugate, 0.1mg/mL
Eosinophil Peroxidase (AHE-1), CF594 conjugate, 0.1mg/mL
CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL
